Ouster, Inc. (OUST) Presents at Oppenheimer 29th Annual Technology, Internet & Communications Conference Transcript

Ouster highlighted 14 consecutive quarters of revenue growth and a ~$55 million (+/−) run rate as it transitions from REV7 to REV8. In Q2—the first full quarter of its unified platform—management said ex-royalties product performance outperformed expectations, and it expects product revenue to be sequentially higher in Q3. REV8 has garnered multimillion-dollar orders (from both new and existing customers), with additional momentum from the launch of Stereolabs Nano for robotics.

Analysis

The key market mechanism here is not the headline launch, but whether REV8 compresses the gap between bookings and cash revenue while lifting mix toward higher-margin product. If the new platform reduces integration/support cost and simplifies SKU complexity, OUST can get operating leverage even before absolute revenue inflects materially; that matters more than the current run-rate because the stock will likely trade on gross margin trajectory and backlog conversion, not just top-line growth.

Second-order, a successful REV8 ramp would pressure smaller lidar peers that are still trying to prove volume with older architectures, especially in industrial/robotics where buyers value fast qualification and reliability over premium specs. The robotics camera launch is strategically useful because it broadens OUST’s attach opportunity in autonomy stacks, but it also raises the bar: management now has to prove cross-sell rather than just single-product adoption. The risk is that “booked orders” stay lumpy and don’t translate into clean quarter-over-quarter shipment cadence.

Over the next 1-3 months, the real catalyst is whether Q3 sequential product growth is accompanied by stable or improving gross margin. If revenue steps up but margin slips, the market will read it as pull-forward or discounting, not durable share gain. Over 6-18 months, this is a balance-sheet-and-execution story: any slip in qualification timing, customer concentration, or industrial capex would quickly unwind the multiple. Falsifier: no sequential product growth, or REV8 mix expansion without margin expansion.

Key Decisions for Investors

• Initiate a small tactical long OUST on post-conference weakness, with a 1-3 month horizon; size for execution risk and use a tight stop if the next update does not confirm sequential product growth.
• Pair trade: long OUST / short LAZR or MVIS to express relative execution in non-automotive lidar and robotics; the thesis only works if OUST converts bookings into revenue faster than peers convert announcements into design wins.
• Set a catalyst alert for OUST's next quarterly report: if product gross margin does not hold or improve alongside sequential revenue growth, exit the long and treat the move as overdone.
• If you want optionality instead of delta, favor a limited-risk call spread over outright equity only if implied vol is not already inflated; otherwise the setup is better as a cash equity trade.